Clinical Trial Update: The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients [Phase 2, Phase 3]

View source ↗

Summary

This document discusses a clinical trial evaluating escitalopram for mood, quality of life, and cognitive function in glioblastoma patients. The trial spans Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: GBM, Depression | Phase 2, Phase 3 | Status: UNKNOWN